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Growth factorsAbstract Platelets can play a crucial role in periodontal regeneration as they are reservoirs of
growth factors and cytokines which are the key factors for regeneration of the bone and maturation
of the soft tissue. Platelet-rich plasma (PRP) and platelet-rich ﬁbrin (PRF) are autologous platelet
concentrates prepared from patient’s own blood. Recent researches are being focused on the devel-
opment of therapeutic alternatives which are easy to prepare, non-toxic or biocompatible to living
tissues and economically cheap that might result in the local release of growth factors accelerating
hard and soft tissue healing. PRF is a natural ﬁbrin-based biomaterial prepared from an anticoag-
ulant-free blood harvest without any artiﬁcial biochemical modiﬁcation that allows obtaining ﬁbrin
membranes enriched with platelets and growth factors. Evidence from the literature suggests the
potential role of PRF in periodontal regeneration and tissue engineering. The slow polymerization
during centrifugation and ﬁbrin-based structure makes PRF a better healing biomaterial than PRP
and other ﬁbrin adhesives. The main aim of this review article is to brieﬂy describe the novel platelet
concentrate PRF and its potential role in periodontal regeneration.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.Contents
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Periodontal disease is deﬁned as a complex, multifactorial dis-
ease characterized by the loss of connective tissue attachment
with destruction of periodontal tissues. The aim of periodontal
therapy is to eliminate inﬂammatory process, prevent the pro-
gression of periodontal disease and also to regenerate the lost
periodontal tissues. Periodontal regeneration is a complex
multifactorial process involving biologic events like cell adhe-
sion, migration, proliferation, and differentiation in an orches-
trated sequence.1 Periodontal regenerative procedures include
soft tissue grafts, bone grafts, root biomodiﬁcations, guided
tissue regeneration, and combinations of these procedures.2
The current perspective is that regenerative periodontal thera-
pies to date can only restore a fraction of the original tissue
volume 2 and have a limited potential in attaining complete
periodontal restoration.3 Various biomaterials have been used
for periodontal tissue regeneration in addition to autogenous
and allogenic bone grafts but not a single graft material is con-
sidered as gold standard for the treatment of intrabony defects.
Periodontal wound healing requires a sequence of interac-
tions between epithelial cells, gingival ﬁbroblasts, periodontal
ligament cells, and osteoblasts. The disruption of vasculatureFigure 1 Test tube showing platelet-rich ﬁbrin after centrifuga-
tion of blood.during wound healing leads to ﬁbrin formation, platelet aggre-
gation, and release of several growth factors into tissues from
platelets4 through molecular signals which are primarily med-
iated by cytokines and growth factors. There is evidence that
the presence of growth factors and cytokines in platelets play
key roles in inﬂammation and wound healing.5 Platelets also
secrete ﬁbrin, ﬁbronectin, and vitronectin, which act as a ma-
trix for the connective tissue and as adhesion molecules for
more efﬁcient cell migration.6 This has led to the idea of using
platelets as therapeutic tools to improve tissue repair particu-
larly in periodontal wound healing.
Platelet-rich ﬁbrin (PRF) described by Choukroun et al.7 is
a second-generation platelet concentrate which contains plate-
lets and growth factors in the form of ﬁbrin membranes pre-
pared from the patient’s own blood free of any anticoagulant
or other artiﬁcial biochemical modiﬁcations. The PRF clot
forms a strong natural ﬁbrin matrix, which concentrates al-
most all the platelets and growth factors of the blood harvest8,9
and shows a complex architecture as a healing matrix with un-
ique mechanical properties which makes it distinct from other
platelet concentrates. PRF enhances wound healing and regen-
eration and several studies show rapid and accelerated wound
healing with the use of PRF than without it.10,11 PRF is supe-
rior to other platelet concentrates like PRP due to its ease and
inexpensive method of preparation and also it does not need
any addition of exogenous compounds like bovine thrombin
and calcium chloride. It is advantageous than autogenous graft
also because an autograft requires a second surgical site and
procedure. Thus PRF has emerged as one of the promising
regenerative materials in the ﬁeld of periodontics. This review
article explains the novel platelet concentrate PRF, its prepara-
tion, clinical applications and beneﬁts and drawbacks over
other biomaterials.
2. Role of platelets in periodontal wound healing
Platelets play a key role in wound healing and hence wound
healing after periodontal treatment can be accelerated by the
use of platelet concentrates. The wound healing process initi-
ated by the formation of blood clot and after tissue injury in
periodontal surgery causes adherence and aggregation of
platelets favoring the formation of thrombin and ﬁbrin. In
addition, there is release of certain substances from platelets
that promote tissue repair, angiogenesis, inﬂammation and im-
mune response. Platelets also contain biologically active
proteins and the binding of these secreted proteins within a
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chemotactic gradients favoring the recruitment of the stem
cells, stimulating cell migration, differentiation, and promoting
repair. Thus the use of autologous platelet concentrates is a
promising application in the ﬁeld of periodontal regeneration
and can be used in clinical situations requiring rapid healing.
3. What is PRF?
PRF (platelet rich ﬁbrin) was ﬁrst developed in France for use
in the ﬁeld of oral and maxillofacial surgery.7 Choukroun’s
platelet-rich ﬁbrin (PRF) is a leukocyte and platelet rich ﬁbrin
biomaterial12 with a speciﬁc composition and three-dimen-
sional architecture. PRF is classiﬁed as a second generation
platelet concentrate as it is prepared as a natural concentrate
without the addition of any anticoagulants.13,14 PRF is often
called Choukroun’s PRF as there are other platelet concen-
trates with similar names such as Vivostat PRF (considered
a pure platelet-rich plasma) or Fibrinet PRF (without leuko-
cytes). PRF has a dense ﬁbrin network with leukocytes, cyto-
kines, structural glycoproteins15 and also growth factors such
as transforming growth factor b1, platelet-derived growth fac-
tor, vascular endothelial growth factor and glycoproteins such
as thrombospondin-1 during P7 day.16 Leukocytes that are
concentrated in PRF scaffold play an important role in growth
factor release,16 immune regulation,9 anti-infectious activi-
ties,17 and matrix remodeling during wound healing. The slow
polymerization mode of PRF and cicatricial capacity creates a
physiologic architecture favorable for wound healing.18
4. Historical background
Platelets are used as powerful tools for periodontal regeneration
for the past two decades due to the key role of platelets in wound
healing process. Although the use of ﬁbrin adhesives is well doc-
umented from the past 30 years19,20 their use is still controversialFigure 2 Platelet-rich ﬁbrin after centrifugation.due to the complexity in preparation and risk of cross-infection.
After that concentrated platelet-rich plasma (cPRP) was devel-
oped with a less complex production protocol. It is prepared
from the patient’s own blood and is activated by the addition
of thrombin and calcium. The structure consists of a three
dimensional biocompatible ﬁbrin scaffold with a limited volume
of plasma enriched in platelets. When PRP is activated the
growth factors and proteins are released to the local environ-
ment accelerating postoperative wound healing and tissue re-
pair.18 But the disadvantage of using PRP is that its properties
can vary depending on the concentration of platelets, amount
of leukocytes, the type of activator used and time of placement
of ﬁbrin scaffold after clotting. But there are certain risks asso-
ciated with the use of PRP.21 The presence of bovine thrombin
inPRPcan result in the development of antibodies to the clotting
factors V, XI and thrombin which can adversely affect the coag-
ulation process. In addition, bovine thrombin preparations con-
tain clotting factor V which can result in immune system
activation when challenged with a foreign protein. Other draw-
backs about the use of PRP include legal restrictions onhandling
the blood and also controversies in the literature regarding the
beneﬁts and clinical outcome of use of PRP. All these have led
to the generation of a new family of platelet concentrate called
platelet-rich ﬁbrin which overcomes many of the limitations of
PRP. PRF is a potent autologous regenerative material with
many clinical applications in the ﬁeld of periodontics as it accel-
erates both soft tissue and hard tissue healing.
5. Potential beneﬁts of using PRF in periodontal regeneration
Platelet-rich ﬁbrin is a second generation platelet concentrate
which can enhance both soft and hard tissue healing. Its advanta-
ges over platelet-rich plasma include ease of preparation, ease of
application, minimal expense, and lack of biochemical modiﬁca-
tion (no bovine thrombin or anticoagulant is required). This con-
siderably reduces the biochemical handling of blood as well as
risks associated with the use of bovine-derived thrombin. PRF
also contains physiologically available thrombin that results in
slow polymerization of ﬁbrinogen into ﬁbrin which results in a
physiologic architecture that is favorable to wound healing.
The cytokines which are present in platelet concentrates
play an important role in wound healing. The structuralFigure 3 Platelet-rich ﬁbrin after collection.
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ﬁbrin meshes is different from that present in PRP. The natural
polymerization in PRF results in increased incorporation of the
circulating cytokines in the ﬁbrin meshes (intrinsic cytokines).
These intrinsic cytokines will be having an increased lifespan
and they will be released and used only at the time of initial cic-
atricial matrix remodeling which creates a long term effect. In
PRP and other ﬁbrin adhesives the presence of artiﬁcial addi-
tives like bovine thrombin and calciumchloride results in sudden
ﬁbrin polymerization causing loss of synergy between cytokines
and ﬁbrin with faster physiologic elimination of these cytokines.
The threedimensionalorganizationofaﬁbrinnetwork inPRF
and PRP affects the biologic and mechanical properties of these
platelet concentrates. During gelling of these ﬁbrin structures,
the ﬁbrin ﬁbrillae can be assembled in 2 ways, bilateral junctions
or equilateral junctions. In PRP there are bilateral junctions with
strong thrombin concentrations that allow thickening of ﬁbrin
polymer with a rigid network resulting in poor cytokine entrap-
ment and cellularmigration. But in PRF the equilateral junctions
are present with weak thrombin concentrations forming a ﬁne
andﬂexibleﬁbrinnetworkwhich ismore elastic innature favoring
cytokine entrapment and cellular migration.8 All these compara-
tive parametersmake PRF a better healing biomaterial than PRP
and other ﬁbrin adhesives.
Another added advantage of PRF is the presence of natural
ﬁbrin network in PRF which protects the growth factors from
proteolysis.12,22 PRF also favors the development of microvas-
cularization leading to a more efﬁcient cell migration.6. Protocol for preparation of PRF
The classical technique for PRF preparation was invented by
Dr. Choukroun7 in 2000. It is the current PRF technique
authorized by the French Health Ministry in which PRF is
prepared without using an anticoagulant during blood harvest-
ing or bovine thrombin during gelling.6
A standard protocol for PRF preparation should be
followed to obtain proper quantity and quality of the ﬁbrin
matrix, leukocytes, platelets, and growth factors. The equip-
ment required for PRF preparation includes a PC-02 table cen-
trifuge and a blood collection kit consisting of a 24 gauge
butterﬂy needle and 9 ml blood collection tubes. A sample of
blood is collected from patient without anticoagulant in
10 ml tubes which are immediately centrifuged at a rate of
3000 rpm for 10 min. During the centrifugation process, when
the blood gets in contact with the test tube wall the platelet gets
activated leading to the initiation of coagulation cascade. After
centrifugation, the resultant product consists of three layers.
The topmost layer consisting of acellular PPP (platelet poor
plasma), PRF clot in the middle and RBCs at the bottom of
the test tube (see Fig. 1). The ﬁbrin clot obtained after centri-
fugation is removed from the tube and the attached red blood
cells scraped off from it and discarded (see Fig. 2). PRF can
also be prepared in the form of a membrane by squeezing
out the ﬂuids present in the ﬁbrin clot.
The duration of time between blood collection and centrifu-
gation process is an important parameter affecting the success
and clinical outcome of this procedure. The slow handling of
blood to centrifugation process will result in diffuse polymeriza-
tion of ﬁbrin leading to the formation of a small blood clot with
irregular consistency. Hence a reproducible protocol for PRFproduction should be followed to obtain a clinically usable ﬁbrin
clot with massive enmeshment of platelets (see Fig. 3).
7. Clinical applications
PRF is a powerful healing biomaterial with inherent regenera-
tive capacity and can be used in various procedures such as for
the treatment of periodontal intrabony defects,10,11 treatment
of furcation,23 sinus lift procedures24 and as a scaffold for hu-
man periosteal cells in vitro, which ﬁnds application in the ﬁeld
of tissue engineering.25
8. Evidence for the role of PRF in periodontal regeneration
PRF is enriched with platelets, growth factors and cytokines
increasing the healing potential of both hard and soft tissue.4,5
There are only a few references in the literature about the biologic
properties of PRFwhen compared to other platelet concentrates.
The literature mostly contains animal and human studies of the
experimental use of PRF and only limited in vitro studies have
been carriedouton the effectsofPRFoncell proliferation. Inspite
of the lack of scientiﬁcally proven clinical beneﬁts, PRF is consid-
ered as a healing biomaterial and is commonly used in implant
and plastic periodontal surgery procedures to enhance bone
regeneration and soft-tissue wound healing.26,27 According to
Choukron et al. PRF was initially used in implant surgery to en-
hance the healing properties of the bone.7 PRF can promote the
healing of osseous defects by the following mechanisms. Accord-
ing to Chang et al. PRF promotes the expression of phosphory-
lated extracellular signal-regulated protein kinase (p-ERK) and
stimulates the production of osteoprotegerin (OPG)which inturn
causes proliferation of osteoblasts.28 Another study by Huang
et al. reported that PRF stimulates the osteogenic differentiation
of the human dental pulp cells by upregulating osteoprotegerin
and alkaline phosphatase expression.29 PRF also releases growth
factors such as platelet-derived growth factor and transforming
growth factorwhich promote periodontal regeneration.8,9 Chang
et al. in a study reported thatPRF stimulates cell proliferation in a
speciﬁc manner.30 PRF induces cell proliferation of osteoblasts,
periodontal ligament cells and growth factors during a 3-day cul-
ture period and suppressed oral epithelial cell growth. These cell
type-speciﬁc actions may be beneﬁcial for periodontal regenera-
tion. Diss et al. in a 1 year prospective study on osteotome sinus
ﬂoor elevation using Choukroun’s platelet-rich ﬁbrin grafting
material clearly demonstrated that ﬁbrin matrix of PRF directly
promotes angiogenesis.31 PRF when used as a membrane for
guided tissue regeneration as a grafting material creates an im-
proved spacemaking effect which facilitates cell events that are
favorable for periodontal regeneration leading tomineralized tis-
sue formation. PRF is having an inherent osteoconductive and/or
osteoinductive propertywhich is beneﬁcial for regenerationof the
bone. Sanchez et al. in an experimental study compared the inﬂu-
ence ofPRPandPRFonproliferation anddifferentiationof oste-
oblasts and he reported that the afﬁnity of osteoblasts to the PRF
membrane appeared tobe superior than the afﬁnityof osteoblasts
to PRP.21 Sharma et al. conducted a randomized controlled clin-
ical trial for the treatment of 3-wall intrabony defects in chronic
periodontitis patientswithplateletrichﬁbrinandreporteda statis-
tically signiﬁcant improvement in pocket depth reduction and
bone ﬁll in test group than in controls.10 A similar study was con-
ducted for the treatmentofmandibulardegree II furcationdefects
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pocket depth reduction, gain in clinical attachment level andbone
ﬁll in test groupwhen compared to controls.23 Thorat et al. inves-
tigated the clinical and radiological effectiveness of autologous
PRF in the treatmentof intrabonydefectsof chronicperiodontitis
patients and reported a greater reduction in pocket depth, more
gain in clinical attachment level and greater intrabony defect ﬁll
at sites treated with PRF than those treated with open ﬂap
debridement alone.11 Another randomized controlled clinical
trial was done in three treatment groups comprising of OFD
(open ﬂap debridement) + PRF, OFD+ PRF+HA (porous
hydroxyapatite graft) and OFD alone as control. This study
showed a signiﬁcant bone ﬁll in plateletrich ﬁbrin treated group
than in controls and a signiﬁcant bone ﬁll and gain in clinical
attachment level in plateletrich ﬁbrin combined with porous
hydroxyapatitegraft than incontrolgroup.32Acomparative eval-
uationbetweenplatelet-richﬁbrinandplatelet-richplasma for the
treatment of three-wall intrabony defects was done and showed a
greater bone ﬁll in PRF treated group than in PRP treated
group.33 The effect of platelet-rich ﬁbrin on human periodontal
ligament ﬁbroblasts and application in periodontal infrabony de-
fects was studied by Chang et al. and reported that PRF was
found to increase extracellular signal-regulated protein kinase
phosphorylation and osteoprotegerin in periodontal ligament
ﬁbroblasts and upregulation of alkaline phosphatase activity.
Also, infrabony defects exhibited pocket reduction and clinical
attachment gain after six months with bone ﬁll in defects.34
9. Evidence for the role of PRF in tissue engineering
The a-granules present in platelets contain growth factors like
platelet derived factor (PDGF), transforming growth factor-b
(TGF-b), vascular endothelial growth factor (VEGF), and epi-
dermal growth factor (EGF).35 Platelet derived growth factor
(PDGF) has an important role in periodontal regeneration
and wound healing36 and receptor for PDGF is present on gin-
giva, periodontal ligament and cementum and it activates ﬁbro-
blasts and osteoblasts promoting protein synthesis37 PDGF also
functions as a chemoattractant for ﬁbroblasts and osteoblasts in
gingiva and periodontal ligament resulting in their activation.38
PRF promotes angiogenesis because as it has low thrombin le-
vel optimal for the migration of endothelial cells and ﬁbroblasts.
PRF entraps circulating stem cells due to its unique ﬁbrin struc-
ture. This property of PRF ﬁnds application in healing of large
osseous defects where there is migration of stem cells differenti-
ating into osteoblast phenotype.26 PRF also helps in facilitating
adhesion and spreading of cells, regulates gene expression of
growth factors, growth factor receptors, proteins, and deter-
mines the outcome of a cell’s response to growth factors due
to the presence of collagen, ﬁbronectin, elastin, other non-col-
lagenous proteins, and proteoglycan in the extracellulat matrix
of PRF.39 The use of PRF as a tissue engineering scaffold
was investigated by many researchers for the past few years.
In a study by Gassling et al. reported that PRF appears to be
superior to collagen as a scaffold for human periosteal cell pro-
liferation and PRF membranes can be used for in vitro cultiva-
tion of periosteal cells for bone tissue engineering.25 PRF has
immune functions like chemotaxis as leukocytes present in
PRF degranulates during activation and releases cytokines like
IL-1, IL-4, IL-6 and TNF-a. PRF also contains anti-inﬂamma-
tory cykokine such as IL-4 which requires further research.9Thus PRF is a potential tool in tissue engineering but clinical
aspects of PRF in this ﬁeld requires further investigation.
10. Drawbacks of PRF
The main shortcoming of PRF is its preparation and storage.
The clinical beneﬁt of PRF depends on time interval between
speed of handling between blood collection and centrifugation
as PRF is prepared without any addition anticoagulants.
Another main disadvantage of PRF is its storage after
preparation.40 Also PRF membranes should be used immedi-
ately after preparation as it will shrink resulting in dehydration
altering the structural integrity of PRF.Dehydration also results
in the decreased growth factor content in PRF16 and leukocyte
viability will be adversely affected altering its biologic proper-
ties. PRF when stored in refrigerator can result in risk of bacte-
rial contamination of themembranes. These limitations with the
use of PRFcanbe circumvented by sticking onto a standard pro-
tocol for preparation and preservation.
11. Future directions
In the future more studies should be carried out to correlate
the clinical outcome of PRF with its biologic mechanisms
which opens novel applications of this autologous platelet
concentrate. There are only limited studies in the literature
on the effect of PRF on cell proliferation and other biologic
effects. Therefore, more studies should be conducted which
open newer strategies for the use of this platelet concentrate.
12. Conclusion
PRF by Choukroun’s technique is a simple and inexpensive
technique for the successful regeneration of periodontal
tissues. The main advantage is that PRF preparation utilizes
the patient’s own blood reducing or eliminating disease
transmission through blood. In the future more studies and
clinical trials are needed to investigate potential applications
of PRF in the ﬁeld of periodontal regeneration and tissue
engineering and to extend its clinical applications.
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